We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Biomarkers Distinguish Latent from Active TB

By LabMedica International staff writers
Posted on 02 Aug 2010
Print article
Multicytokine profiles of patients can determine if they have active or dormant tuberculosis (TB).

A pattern of two cytokines was reasonably good at differentiating between persons sick with TB and persons infected but not ill. In addition, a third cytokine looks promising in distinguishing between uninfected persons and infected individuals.

Cytokines are proteins that are secreted by cells and regulate the behavior of other cells by binding to receptors on their surfaces. This binding triggers a variety of responses, depending on the nature of the cytokine and the target cell.

In a study, carried out at Duke University Medical Center (Duke University; Durham, NC, USA), whole blood samples were collected from 71 people belonging to one of three groups: those with active TB, those with latent TB infection, and those who were not infected with Mycobacterium tuberculosis. The blood samples were exposed overnight with mitogen (positive control), saline (negative control), and a mixture of three tubercles bacillus antigens that stimulated an immune response. Scientists then measured the levels of 25 specific cytokines, to determine the presence of a pattern that could allow them to differentiate among the three groups.

Four cytokines had significantly greater response to stimulation in TB-infected persons (active or latent) than in uninfected persons: interferon gamma, IP-10, MCP-1, and IL-15. Of these, two cytokines had significantly greater responses to stimulation among persons with active TB than persons with latent TB: MCP-1 where the median response was 30,000 pg/mL in active TB and 11,100 pg/mL in latent TB. For IL-15 the median response in active TB was 152 pg/mL and 35 pg/mL in latent TB. A combination of MCP-1 and IL-15 at cutoffs of greater than 25,000 pg/mL and 80 pg/mL respectively, correctly categorized 10 of 12 active TB infections and 28 of 32 latent TB infections.

The resurgence of tuberculosis has resulted in the declaration of a global health emergency by the World Health Organization (WHO, Geneva, Switzerland, www.who.int). Every year, nearly half a million new cases of multidrug-resistant tuberculosis (MDR-TB) are estimated to occur worldwide. Jason Stout, M.D., M.H.S., assistant professor at Duke University, said, "Generally a culture is required to tell the difference between latent infection and active tuberculosis, but a culture usually requires weeks to deliver a result. A rapid test that could tell the difference between latent and active tuberculosis would be a major step forward.” The findings were reported at the American Thoracic Society International Conference held in New Orleans in May 2010.

Related Links:

Duke University Medical Center
WHO


Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
New
Fecal DNA Extraction Kit
QIAamp PowerFecal Pro DNA Kit

Print article

Channels

Molecular Diagnostics

view channel
Image: Researcher Kanta Horie places a sample in a mass spectrometer that measures protein levels in blood plasma and other fluids (Photo courtesy of WashU Medicine)

Highly Accurate Blood Test Diagnoses Alzheimer’s and Measures Dementia Progression

Several blood tests are currently available to assist doctors in diagnosing Alzheimer's disease in individuals experiencing cognitive symptoms. However, these tests do not provide insights into the clinical... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.